Swedish Biotech Breakthroughs

Guard Therapeutics International

Market Cap: SEK 326.7m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.7b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Active Biotech

Market Cap: SEK 296.5m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.1b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Mendus

Market Cap: SEK 258.8m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Initiator Pharma

Market Cap: SEK 218.5m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Diamyd Medical

Market Cap: SEK 952.8m

Develops precision medicine therapies for the treatment of autoimmune diabetes.